NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement to collaborate with Kyowa Hakko Kirin on glycomics studies using Ezose's GlycanMap platform.
Under terms of the deal, Kyowa Hakko Kirin will provide funding for several glycan biomarker efforts and other discovery projects, said Pine Brook, NJ-based Ezose. Financial and other terms of the collaboration were not disclosed.
Ezose's GlycanMap platform combines MALDI-TOF mass spectrometry with bioinformatics to structurally identify and quantitate glycans present in complex biological samples. The glycans can be used in developing therapeutics or diagnostics, including companion diagnostics, said Ezose.